🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tailored, precision treatments are vital as genetic variation between patients means that there is no 'one size fits all' approach in the fight against cancer #AdFeature with Caris Life Sciences

Dr. John Marshall's Poster Session "Association of BRCA-mutant pancreatic cancer with high tumor mutational burden (TMB) and higher PD-L1 expression". ASCO

Payers would actually profit by paying for comprehensive molecular profiling that allows patients to enroll on clinical trials #asco2019

Dr. Lee Schwartzberg reports on this past year’s progress of the ACCC initiative to speed adoption of immunotherapeutics in community practices. Click the link to watch the full video ascopost.com/videos/2019-as…

Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients? | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.12…

Pediatric MATCH trial finds more frequent targetable genetic alterations in childhood cancers than predicted: cancer.gov/news-events/ca… #childhoodcancer ASCO #ASCO19

Increasing role for #Biomarker #profiling in breast cancer! Analysis Predicts Response to Adjuvant Trastuzumab, Pertuzumab in HER2+ Breast Cancer #ASCO19 dailynews.ascopubs.org/do/10.1200/ADN…

Honored to work along side such great minds to progress the understanding of MBM! A hot topic indeed. #ASCO19

Meet Medical Oncologist Dr. Ben Weinberg who specializes in gastrointestinal cancers including colorectal and pancreatic cancer. Benjamin Weinberg, MD, FACP youtube.com/watch?v=e_bd79…

Valid points to consider given the cost and potential toxicities of immunotherapies.

Yousuf Zafar, MD MHS @sloan_kettering Emil Lou, MD, PhD, FACP @SalemGIoncology Pashtoon Kasi MD, MS Gabriel Brooks chadi nabhan MD, MBA, FACP Thomas George, MD, FACP, FASCO Wafik S. El-Deiry, MD, PhD, FACP Richard Dunne, MD Mark Lewis, MD, FASCO I disagree with LS. Working West Cancer Center & Research Institute where every pt with advanced cancer has access to comprehensive molecular profiling, I can attest to its value. In our MolecularTumorBoard we have seen e.g. 3 pts w/ NTRK fus, 2 w/ POLe mut, 1 MSI-H breast ca in last 6 mos. Huge impact!

Gregory Vidal, MD, PhD & Lee Schwartzberg, MD, FACP co-authored a study presented at #ASCO19 that evaluated the relationship between homologous recombination deficiency and the presence of additional mutations that may impact responsiveness to targeted therapies.

Prognostic value of B cells in cutaneous melanoma | Genome Medicine | Full Text genomemedicine.biomedcentral.com/articles/10.11…

At #ASCO19, Lee Schwartzberg of West Cancer Center & Research Institute shared an update on the use of immunotherapy in the community setting: ASCO vimeo.com/339735735

IDH mutations block transcription factor-mediated differentiation in mesenchymal cells; effects on chromatin remodeling, H3K9 hypermethylation, and impaired accessibility at myogenic chromatin regions. Juanma Schvartzman @sloan_kettering. Beautiful work! pnas.org/content/early/…

Axel Grothey, MD, co-authored a study presented at #ASCO19 on microsatellite instable/deficient mismatch repair metastatic colorectal cancers which have a poor prognosis. media4.asco.org/239/13721/1718…

“There is a special place in heaven for women who support other women.” @azwcc forbes.com/sites/shelleyz…

Well I haven’t been climbing much but been training like whoa 😳

Canadian friends, any one want to adopt a 32yro scientist? Very quite and tidy and will belay on command. Hobbies include rock climbing, RPGs, and crafts.

Front row seat to learn about breast cancer from a legend. George W Sledge MD presents to the Caris Life Sciences Precision Oncology Alliance.